Qsemble Capital Management, LP Biomarin Pharmaceutical Inc Transaction History

Qsemble Capital Management, LP

  • $543 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
SELL
$83.81 - $99.0 $80,457 - $95,040
-960 Reduced 9.79%
8,848 $773 Million
Q4 2023

Feb 07, 2024
SELL
$76.22 - $98.51 $654,882 - $846,397
-8,592 Reduced 46.7%
9,808 $946 Million
Q3 2023

Nov 07, 2023
BUY
$85.07 - $94.48 $603,997 - $670,808
7,100 Added 62.83%
18,400 $1.63 Billion
Q2 2023

Aug 11, 2023
BUY
$86.68 - $100.3 $979,484 - $1.13 Million
11,300 New
11,300 $979 Million
Q4 2022

Feb 09, 2023
BUY
$80.93 - $108.63 $655,533 - $879,903
8,100 New
8,100 $838 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Qsemble Capital Management, LP Portfolio

Follow Qsemble Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qsemble Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Qsemble Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email